Abstract
In the article “High Prevalence of Neutralizing Antibodies After Long-term Botulinum Neurotoxin Therapy” by Albrecht et al.,1 the third sentence of the Conclusions paragraph in the Abstract should read: “However, in addition to avoiding booster injections and extending the interval between injections, reducing the individual injected doses may diminish the risk of NAb induction independently of the indication for which BoNT/A is used.” The authors regret the error.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
